InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Empfield James R., Vice-Président Exécutif, Découverte de Médicaments. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 4 March 2022. The latest transaction was disclosed on 12 August 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
EMPFIELD JAMES R. serves as Executive Vice President of Drug Discovery at Xenon Pharmaceuticals Inc. He leads research and development efforts to discover new treatments. His expertise contributes to innovation and advancement of the company's pharmaceutical projects.